Literature DB >> 10518133

False negative cytologic diagnosis of breast carcinoma.

P Dey1, U K Luthra.   

Abstract

OBJECTIVE: To study the reasons for interpretive errors in false negative diagnosis of breast carcinoma on fine needle aspiration cytology material. STUDY
DESIGN: We reviewed only those histologically proved malignant cases where the cytologic material was abnormal and to some extent misinterpreted.
RESULTS: There were four lobular carcinomas and one each case of in situ, infiltrating duct, medullary and tubular carcinoma. Smears of lobular carcinomas were hypocellular overall, and the cells showed minimal nuclear pleomorphism. In situ, medullary and tubular carcinoma were associated with fibrocystic changes. The presence of bipolar cells and stromal fragments was misleading in cases of infiltrating duct carcinoma.
CONCLUSION: The presence of associated fibrocystic disease may be a misleading factor since it may mask a malignancy. Hypocellularity and relatively nuclear monomorphism were the most common reasons for failure to diagnose malignant breast lesions. Careful attention should be paid to extreme nuclear monomorphism and absence of naked bipolar cells. A cytologically atypical or suspicious diagnosis together with radiologic suspicion should suggest a diagnosis of malignancy.

Entities:  

Mesh:

Year:  1999        PMID: 10518133     DOI: 10.1159/000331293

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  2 in total

1.  The clinical effectiveness of fine needle aspiration biopsy in patients with palpable breast lesions seen at the University College Hospital, Ibadan, Nigeria: A 10-year retrospective study.

Authors:  Cornelius O Ukah; Olayiwola A Oluwasola
Journal:  J Cytol       Date:  2011-07       Impact factor: 1.000

2.  Cytological study of palpable breast lumps presenting in an Indian rural setup.

Authors:  Smita Balwantrao Sankaye; Suyrakant Dattatreya Dongre
Journal:  Indian J Med Paediatr Oncol       Date:  2014-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.